NCT01815970

Brief Summary

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death world-wide. Dyspnea (i.e., sensations of breathlessness) is the hallmark symptom of patients with this disease. Pulmonary rehabilitation programs that incorporate exercise training remain the most effective non-pharmacological method of reducing dyspnea in COPD, however it is not understood how exercise training relieves dyspnea. Accordingly, the purpose of this study is to determine if pulmonary rehabilitation can reduce the disparity between the drive to breathe and the breathing response in patients with COPD and to determine if this reduction is associated with improvements in dyspnea during exercise. The investigators hypothesise pulmonary rehabilitation will reduce dyspnea at a standardized work rate and this reduction will be directly related to an improvement in the breathing response.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 21, 2013

Completed
5.1 years until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 17, 2018

Status Verified

January 1, 2018

Enrollment Period

1.6 years

First QC Date

March 11, 2013

Last Update Submit

January 12, 2018

Conditions

Keywords

dyspneaexerciseneuromechanical uncouplingCOPDpulmonary rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in neuromechanical uncoupling

    The relationship between the neural drive (or effort) to breathe and the corresponding mechanical response of the respiratory system.

    Parameters will be measured during the 3 visits, at rest and during exercise. Visits 1 & 2 will be 48 hrs apart and within 2 weeks prior to the 8 week pulmonary rehabilitation (PR). Visit 3 will occur within 2 weeks after the completion of the PR.

Secondary Outcomes (1)

  • Dyspnea

    Parameters will be measured during the 3 visits, at rest and during exercise. Visits 1 & 2 will be 48 hrs apart and within 2 weeks prior to the 8 week pulmonary rehabilitation (PR). Visit 3 will occur within 2 weeks after the completion of the PR.

Study Arms (1)

Pulmonary Rehabilitation

EXPERIMENTAL

8 weeks of Pulmonary Rehabilitation

Behavioral: Pulmonary Rehabilitation

Interventions

8 weeks of Pulmonary Rehabilitation including exercise and COPD related education.

Pulmonary Rehabilitation

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A physician diagnosis of moderate-to-severe COPD
  • Stable clinical COPD status (no history of an acute exacerbation requiring antibiotics or prednisone in the past 4 weeks)
  • Post-bronchodilator Forced Expiratory Volume in 1 second (FEV1.0) ≥ 30 - \< 80% predicted and FEV1.0/Forced Vital Capacity ratio \< 0.7
  • Body mass index \> 18 or \< 35 kg/m2
  • Able to read and understand English

You may not qualify if:

  • Concurrent participation in or recent completion (\<6 weeks) of pulmonary rehabilitation
  • An ulcer or tumor in their esophagus, or a nasal septum deviation (as reported by the participant)
  • Had recent nasopharyngeal surgery
  • Have a cardiac pacemaker
  • Allergies to latex and sensitivities to local anesthetics
  • Uncontrolled hypertension
  • Diagnosis of diabetes
  • Previous physician diagnosis of cardiovascular disease including: angina, acute coronary syndrome, heart failure, cerebrovascular disease, thromboembolic disease, peripheral vascular disease
  • Other chronic lung disease including: asthma, interstitial lung disease, or pulmonary hypertension
  • Chronic hepatic disease, chronic renal disease, or other systemic inflammatory disease
  • Use of chronic oral steroids
  • Dementia or uncontrolled psychiatric illness
  • A disease other than COPD that could contribute to dyspnea or exercise limitation
  • Contraindications to clinical exercise testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UBC James Hogg Research Centre, St. Paul's Hospital

Vancouver, British Columbia, V6Z1Y6, Canada

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveDyspneaMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsBehavior

Study Officials

  • Jordan A Guenette, Ph.D.

    UBC James Hogg Research Centre/ UBC Dept. Physical Therapy

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 11, 2013

First Posted

March 21, 2013

Study Start

May 1, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

January 17, 2018

Record last verified: 2018-01

Locations